cover image - Hematopathology, 3rd Edition
ISBN: 9780323831659
Copyright: 2025
Publication Date: 09-04-2024
Page Count: 1312
Imprint: Elsevier
List Price: $314.99

Hematopathology, 3rd Edition

by Elaine Sarkin Jaffe, MD, Daniel A. Arber, MD, Elias Campo, MD, Leticia Quintanilla-Fend, MD, Attilio Orazi, MD, Lisa M. Rimsza, MD and Steven H. Swerdlow, MD

Hardcover

cover image - Hematopathology, 3rd Edition
ISBN: 9780323831659
Copyright: 2025
Publication Date: 09-04-2024
Page Count: 1312
Imprint: Elsevier
List Price: $314.99
    • Helps you navigate the latest changes in the classification of hematolymphoid neoplasms, providing guidance for use of both the International Consensus Classification (ICC) and 5th edition of the WHO classification.
    • Incorporates the latest molecular/cytogenetic information, regarding newly recognized entities and the latest diagnostic criteria.
    • Provides you with today's most effective guidance in evaluating specimens from the lymph nodes, bone marrow, peripheral blood, and more, with authoritative information on the pathogenesis, clinical and pathologic diagnosis, and treatment for each.
    • Details the latest insights on the molecular biology of benign and malignant hematologic disorders.
    • Features more than 1,100 high-quality color images that mirror the findings you encounter in practice.
    • Uses an easy-to-navigate, templated format with standard headings in each chapter.
    • Includes information on disease progression and prognosis, helping you better understand the clinical implications of diagnosis.
    • Shares the knowledge and expertise of new editors, Drs. Lisa Rimsza, Attilio Orazi, and Steven Swerdlow, providing expertise in molecular diagnostics, bone marrow and lymph node biopsies.
    • An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date.
  • PART I Technical Aspects
    1 Processing of the Lymph Node Biopsy Specimen
    2 Fine-Needle Aspiration of Lymph Nodes
    3 Immunohistochemistry for the Hematopathology Laboratory
    4 Flow Cytometry
    5 Molecular Pathology of Hematologic Neoplasms
    6 Important Chromosomal Aberrations in Hematologic Neoplasms and Key Techniques to Diagnose Them
    PART II Normal and Reactive Conditions of Hematopoietic Tissues
    7 Normal Lymphoid Organs and Tissues
    8 Reactive Lymphadenopathies
    9 The Normal Bone Marrow
    10 Evaluation of Anemia, Leukopenia, and Thrombocytopenia
    11 Bone Marrow Findings in Inflammatory, Infectious, and Metabolic Disorders
    PART III Lymphoid Neoplasms
    12 Principles of Classification of Lymphoid Neoplasms
    SECTION 1 • MATURE B-CELL NEOPLASMS
    13 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Monoclonal B-Cell Lymphocytosis, and B-Cell Prolymphocytic Leukemia
    14 Lymphoplasmacytic Lymphoma and Waldenström Macroglobulinemia
    15 Hairy Cell Leukemia
    16 Splenic Marginal Zone Lymphoma and Other Small B-Cell Neoplasms in the Spleen
    17 Follicular Lymphoma
    18 Extranodal Marginal Zone Lymphoma: MALT Lymphoma
    19 Primary Cutaneous B-Cell Lymphomas
    20 Nodal Marginal Zone Lymphoma
    21 Mantle Cell Lymphoma
    22 Aggressive B-Cell Lymphomas Including Diffuse Large B-Cell Lymphoma, Not Otherwise Specified and Other Nodal and Extranodal Large B-Cell Lymphomas
    23 Burkitt Lymphoma, High-Grade B-Cell Lymphoma Not Otherwise Specified, High-Grade B-Cell Lymphoma With MYC and BCL2/BCL6 Rearrangements, Large B-Cell Lymphoma With 11q Aberration, and Provisional Entity High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
    24 Plasmablastic Neoplasms Other Than Plasma Cell Myeloma
    25 Plasma Cell Neoplasms
    26 Nodular Lymphocyte-Predominant B-Cell Lymphoma
    27 Classic Hodgkin Lymphoma
    28 Virally Associated B-Cell Lymphoproliferative Disease
    SECTION 2 • MATURE T-CELL AND NK-CELL NEOPLASMS
    29 Epstein-Barr Virus–Associated T-Cell and Natural Killer–Cell Lymphoproliferative Disorders
    30 T-Cell and NK-Cell Large Granular Lymphocyte Proliferations
    31 T-Cell Prolymphocytic Leukemia
    32 Adult T-Cell Leukemia/Lymphoma
    33 Hepatosplenic T-Cell Lymphoma
    34 Peripheral T-Cell Lymphoma, Not Otherwise Specified
    35 Follicular Helper T-Cell Lymphoma
    36 Anaplastic Large Cell Lymphoma, ALK Positive and ALK Negative
    37 Enteropathy-Associated T-Cell Lymphoma and Other Primary Intestinal T-Cell Lymphomas
    38 Mycosis Fungoides and Sézary Syndrome
    39 Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorders
    40 Primary Cutaneous T-Cell Lymphomas: Rare Subtypes
    SECTION 3 • PRECURSOR B- AND T-CELL NEOPLASMS
    41 Precursor B-Cell and T-Cell Neoplasms
    42 Acute Leukemias of Ambiguous Lineage
    PART IV Myeloid, Histiocytic, and Related Proliferations
    43 Principles of Classification of Myeloid Neoplasms
    44 The Myelodysplastic Syndromes
    45 Myeloid and Hematologic Neoplasms With Germline Predisposition
    46 Acute Myeloid Leukemia
    47 Myeloproliferative Neoplasms
    48 Myelodysplastic/Myeloproliferative Neoplasms and Premalignant Conditions
    49 Mastocytosis
    50 Eosinophilia, Chronic Eosinophilic Leukemia, Not Otherwise Specified, and Myeloid/Lymphoid Neoplasms With Eosinophilia and Tyrosine Kinase Gene Fusions
    51 Blastic Plasmacytoid Dendritic Cell Neoplasm
    52 Histiocytic and Dendritic Cell Proliferations—Systemic and Neoplastic
    PART V Immunodeficiency Disorders
    53 The Pathology of Primary Immunodeficiencies
    54 Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders
    PART VI Site-Specific Issues in the Diagnosis of Lymphoma and Leukemia
    55 Bone Marrow Evaluation for Lymphoma
    56 Evaluation of the Bone Marrow After Therapy
    57 Non-hematopoietic Neoplasms and Other Lesions of the Bone Marrow and Lymph Nodes
    58 Spleen: Normal Architecture and Neoplastic and Non-neoplastic Lesions
    59 Diagnosis of Lymphoma in Extranodal Sites Other Than Skin
    APPENDIX A: THE INTERNATIONAL CONSENSUS CLASSIFICATION OF MYELOID, LYMPHOID, AND HISTIOCYTIC NEOPLASMS
    INDEX

  • Elaine Sarkin Jaffe, MD, Chief, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Clinical Professor of Pathology, George Washington University School of Medicine; Series Editor, World Health Organization Classification of Tumours 4th Edition, International Agency for Research on Cancer, Bethesda, Maryland, Daniel A. Arber, MD, Professor and Chair of Pathology, University of Chicago School of Medicine, USA, Elias Campo, MD, Chief, Hematopathology Unit, Professor of Anatomic Pathology, Clinical Director, Center for Biomedical Diagnosis, Hospital Clinic, University of Barcelona, Barcelona, Spain, Leticia Quintanilla-Fend, MD, Associate Professor, Institute of Pathology, Eberhard-Karls-University; Senior Staff, Institute of Pathology, University Hospital and Comprehensive Cancer Center, Tübingen, Germany, Attilio Orazi, MD, Chair, Department of Pathology, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, Lisa M. Rimsza, MD, Department of Pathology
    Mayo Clinic and Steven H. Swerdlow, MD, Professor of Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA